Researchers crack code of German E. Coli outbreak
A team led by University of Maryland School of Medicine Institute for Genome Sciences researchers has unraveled the genomic code of the E. coli bacterium that caused the ongoing deadly outbreak in Germany that began in May 2011. To date, 53 people have died in the outbreak that has sickened thousand in Germany, Sweden and the U.S. The paper, published July 27 in the New England Journal of Medicine (NEJM), describes how researchers around the globe worked together to use cutting edge technology to sequence and analyze the genomics of E. coli samples from the outbreak as well as closely related strains in a matter of days. They combined those findings with their knowledge of the biology and evolution of the bacteria to learn more about the outbreak. The analysis occurred rapidly enough to inform the physicians treating people who were infected, and assisted epidemiologists as they raced to trace the source of the pathogen.
The research may be the first time that such a comprehensive scientific analysis of an emerging pathogen took place in the first days and weeks of an outbreak, according to the study's lead author, David A. Rasko, Ph.D., assistant professor of microbiology and immunology at the University of Maryland School of Medicine, and a research scientist at the Institute for Genome Sciences.
"This technology is evolving extremely rapidly, enabling us to accomplish much more accurate analysis with unprecedented speed," says Dr. Rasko. "It took years and millions of dollars to sequence the first E. coli genome more than a decade ago. Here we are, just months from the start of the German E. coli outbreak, and we've published a paper on it. This paper and the research it describes represent the new paradigm of outbreak investigations."
The researchers collaborated with Pacific Biosciences of California, Inc., a Menlo Park-based company that used its new Single Molecule Real Time technology to sequence the genome of the E. coli strain from the German outbreak. The collaboration also included scientists from the Statens Serum Institute, the World Health Organization Collaborating Centre for Reference and Research on Escherichia coli and Klebsiella in Denmark, as well as Harvard and the University of Virginia.
"The University of Maryland School of Medicine has a global presence spanning 23 countries, and we are proud that our Institute for Genome Sciences has played a leading role in investigating this international health crisis and improving human health worldwide," says E. Albert Reece, M.D., Ph.D., M.B.A., vice president for medical affairs of the University of Maryland and the John Z. and Akiko K. Bowers Distinguished Professor and dean of the School of Medicine.
Dr. Rasko and colleagues at the Institute for Genome Sciences analyzed the genomic data using computational tools, some of which were developed at the Institute. The Institute for Genome Sciences team included postdoctoral researchers Jason Sahl, Ph.D., and Susan Steyert, Ph.D., and lab manager Julia Redmond. Dr. Rasko's expertise is in the molecular pathogenesis and evolution of E. coli, which helped his team to interpret the massive amount of genomic data involved and learn more about the microbe and how it fits into the overall picture of E. coli.
Scientists found that the genome of the German outbreak E. coli strain was mostly enteroaggregative E. coli, a subtype of the bacteria. In carefully examining its genome, they found that the outbreak strain was actually an unusual combination of enteroaggregative E. coli and another subtype, known as enterohemmorhagic E. coli. Researchers also noted that the strain carried a unique set of virulence and antibiotic resistant factors, making it distinct from other strains of the bacteria.
"This is not just a genome paper. It also examines the virulence and biology of the microbe," says Dr. Rasko. "Early in the outbreak, scientists described bacteria as a 'hybrid' strain. This strain is not a true hybrid, because it contains only a small amount of DNA sequence from enterohemmorhagic E. coli. We have not seen these kinds of unique combinations very often in the past. I expect we are going to see them increasingly, now that technology like Pacific Biosciences' has advanced to the point that we can sequence more strains very rapidly and relatively inexpensively."
"The combination of speed, accuracy and cost will lead genomic sequencing to be a diagnostic tool quicker than anyone currently envisages," says Dr. Sahl, the paper's co-author.
When the outbreak began in May, scientists around the world began examining the E. coli strain as soon as samples were available. Many groups were releasing their findings to the public for free the data in the current study are also publicly available which resulted in a type of "crowd-sourcing," That is, research was being conducted through the collaboration of a large, disparate group around the globe. "Usually, science takes place in relative isolation," says Dr. Rasko. "This is the first time we've seen true 'open source' analysis of a microbial genome."
Very early on in the outbreak, German scientists used another sequencing technology and preliminary analysis to determine was unique about the pathogen associated with the outbreak. In fact, they identified a gene that produced a toxin associated with the very symptoms doctors saw in patients, such as severe diarrhea. This gene, known as the Shiga toxin, is produced more when certain antibiotics are used. The findings meant that patients' symptoms would worsen when they were treated with antibiotics. Those initial findings immediately began to inform clinical care, as doctors stopped using antibiotics to treat infected patients. "Our research is a more detailed, comprehensive analysis than that early research," says Dr. Rasko. "This was an international collaboration pulled together in a matter of days. I expect we will see more collaborations like this to deal with new emerging pathogens in the future."
The NEJM paper will provide new, detailed information to assist researchers and physicians as they continue to investigate the ongoing E. coli outbreak in Europe.
"It's exciting to be at the forefront of genomics like this," says Dr. Rasko. "This research was a chance for us to leverage the power of the Institute for Genome Sciences to help create a new paradigm for the study of microbes and outbreaks. It also has implications for genomics as a tool in routine diagnostics."
Provided by University of Maryland Medical Center
- EHEC 2011 outbreak: Scientists publish their prospective genomic characterization Jul 20, 2011 | not rated yet | 0
- BGI sequences genome of the deadly E. coli in Germany and reveals new super-toxic strain Jun 02, 2011 | not rated yet | 0
- French woman dies of E. coli Jul 02, 2011 | not rated yet | 0
- The complete map of the Germany E. coli O104 genome released Jun 16, 2011 | not rated yet | 0
- Threat to United States from new European E. coli strain unclear Jun 14, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011 I'd like to open a discussion thread for version 2 of the draft of my book ''Classical and Quantum Mechanics via Lie algebras'', available online at http://lanl.arxiv.org/abs/0810.1019 , and for the...
- More from Physics Forums - Independent Research
More news stories
There are significant cost and risk factors associated with two procedures commonly used to diagnose or treat gastrointestinal problems, according to research presented at Digestive Disease Week (DDW).
Diseases, Conditions, Syndromes 1 hour ago | not rated yet | 0
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...
Diseases, Conditions, Syndromes 1 hour ago | not rated yet | 0 |
A new case of the deadly coronavirus has been detected in Saudi Arabia where 15 people have already died after contracting it, the health ministry announced on Saturday on its Internet website.
Diseases, Conditions, Syndromes 14 hours ago | not rated yet | 0
(HealthDay)—Few randomized clinical trials have been done to assess clinical prediction rules for patients with lower back pain, and the trials that have been done are of low quality and do not provide ...
Diseases, Conditions, Syndromes May 17, 2013 | not rated yet | 0 |
A new, highly sensitive blood test that quickly detects even the lowest levels of malaria parasites in the body could make a dramatic difference in efforts to tackle the disease in the UK and across the world, according to ...
Diseases, Conditions, Syndromes May 17, 2013 | not rated yet | 0
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
1 hour ago | 4.5 / 5 (2) | 0 |
Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.
1 hour ago | not rated yet | 0
The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...
1 hour ago | not rated yet | 0
An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).
16 hours ago | not rated yet | 0 |
The latest makeover to a massive psychiatric tome honored by some, reviled by others and even called the "Bible" of mental disorders is being released Saturday with a host of new changes.
13 hours ago | not rated yet | 0
A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...
16 hours ago | 5 / 5 (2) | 0